Stock Taper 
BNY Mellon Strategic Municipals, Inc. is a U.S.-based closed-end fund investing primarily in tax-exempt investment-grade municipal bonds using fundamental analysis.
A closed-end mutual fund that invests primarily in investment-grade municipal bonds. Its main objective is to provide shareholders with current income that is exempt from federal income tax, while preserving capital.
Throughout 2025, BNY Mellon Strategic Municipals, Inc. (LEO) maintained a consistent profile with routine monthly dividend announcements and regular SEC filings. There were no significant product launches, major financial milestones, M&A activities, or other market-moving events that would have placed the company in a major spotlight. While there were changes in institutional ownership and new director appointments, none of these events generated significant media coverage or had a substantial impact on the stock price beyond normal market fluctuations.
Based on publicly available information, BNY Mellon Strategic Municipals, Inc. (LEO), a closed-end fund, did not announce or undergo any significant strategic shifts in 2025. The fund's primary activities during the year consisted of routine operations, including regular monthly dividend distributions and standard regulatory filings, in line with its established investment objective of providing tax-exempt income.
AST SpaceMobile (NASDAQ:ASTS) gained 8.38% to $63.34 in Tuesday trading. The jump came after Washington publicly backed the company's satellite partnership with Japan's Rakuten.
[url="]York Space Systems[/url] (York) (NYSE: YSS), a leading, US-based national defense and commercial prime providing a comprehensive suite of mission-enablin
Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced it has been awarded a contract by [url="]Axiom Space
BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma presents new tralokinumab data at EADV 2026.
Overall rating: B-
| PEER | PRICE | |
|---|---|---|
 GLAD | $18.90 | COMPARE |
 MCI | $18.49 | COMPARE |
 SOR | $45.27 | COMPARE |
 PSBD | $9.64 | COMPARE |
 SAR | $14.90 | COMPARE |
 PNNT | $3.21 | COMPARE |
 SCM | $7.14 | COMPARE |
